Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Nanosonics Limited ( (AU:NAN) ) has shared an update.
Nanosonics Limited issued a notification about a minor typographical correction in a previous announcement related to unquoted equity securities. The update clarified a discrepancy of 1,000 rights allocated to a key management personnel (KMP), reflecting an accurate allocation of 405,184 rights instead of 404,184. While the correction was minor, it demonstrates the company’s commitment to detail, transparency, and maintaining stakeholder trust.
The most recent analyst rating on (AU:NAN) stock is a Buy with a A$5.43 price target. To see the full list of analyst forecasts on Nanosonics Limited stock, see the AU:NAN Stock Forecast page.
More about Nanosonics Limited
Nanosonics Limited operates in the medical technology industry, providing innovative disinfection products and solutions focused on infection prevention in healthcare. Its primary offerings include advanced technologies for preventing the spread of infections, which are widely utilized in medical and healthcare settings.
Average Trading Volume: 592,991
Technical Sentiment Signal: Sell
Current Market Cap: A$1.23B
Find detailed analytics on NAN stock on TipRanks’ Stock Analysis page.